Programmed Death 1 (PD-1) is a member of the CD28/CTLA-4 family of T-cell regulators, expressed as a co-receptor on the surface of activated T-cells, B-cells, and macrophages. New studies have suggested that the PD-1/PD-L1 signaling pathway may be linked to anti-tumor immunity, as PD-L1 has been shown to induce apoptosis of activated T-cells or inhibit activity of cytotoxic T-cells. In comparison to CD10 and bcl-6, PD-1 is expressed by fewer B-cells and has therefore been considered a more specific and useful diagnostic marker for angioimmunoblastic T-cell lymphoma. Therapies targeted toward the PD-1 receptor have shown remarkable clinical responses in patients with various types of cancer, including non–small cell lung cancer, melanoma, and renal-cell cancer.
The PD-1 (IHC001-1) antibody is intended for qualified laboratories to qualitatively identify by light microscopy the presence of associated antigens in sections of formalin-fixed,
paraffin-embedded tissue sections using IHC test methods.
- application:
- IHC
- Catalog number:
- IHC001-1
- clone:
- IHC001
- concentration:
- N/A
- Datasheet:
- formulation:
- Tris Buffer, pH 7.3 - 7.7, with 1% BSA and <0.1% Sodium Azide
- immunogen:
- Recombinant Human His-PD1
- isotype:
- IgG2b
- MSDS:
- N/A
- notes:
- For research use only, not for use in diagnostic procedures.
The datasheet for this product (see above) is intended to serve as an example only. Please refer to the datasheet provided with the antibody for precise details. - Other names:
- N/A
- Protocol:
- N/A
- size:
- 1.0 mL
- storage:
- 2-8°C (Do not freeze).
- Species:
- Human
- Host:
- Mouse